ConductScience.org, home

Paper41300985

Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components.

De Lucia SS and 8 others. Cancers (Basel), 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components. Papers, record 41300985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-11-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1De Lucia SSSara Sofia
2Nista ECEnrico Celestino
3Candelli MMarcellohttps://orcid.org/0000-0001-8443-7880
4Archilei SSebastianohttps://orcid.org/0009-0003-7015-3395
5Deutschbein FFranziska
6Capuano EEnrico
7Gasbarrini AAntoniohttps://orcid.org/0000-0002-6230-1779
8Franceschi FFrancesco
9Pignataro GGiuliahttps://orcid.org/0000-0003-3394-3913

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07486492Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel CancerResults

Source ClinicalTrials.gov

Download CSV of trials

References126

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131578522The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL.Nature2019https://conductscience.org/library/papers/31578522PubMed
236115181Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance.Drug Resist Updat2022https://conductscience.org/library/papers/36115181PubMed
329567829The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.Cancer Discov2018https://conductscience.org/library/papers/29567829PubMed
432145242The link "Cancer and autoimmune diseases" in the light of microbiota: Evidence of a potential culprit.Immunol Lett2020https://conductscience.org/library/papers/32145242PubMed
524899628Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.Protein Eng Des Sel2014https://conductscience.org/library/papers/24899628PubMed
637432351Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota.Nutrients2023https://conductscience.org/library/papers/37432351PubMed
733303685Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.Science2021https://conductscience.org/library/papers/33303685PubMed
833906958Therapeutic potential of microbial modulation in pancreatic cancer.Gut2021https://conductscience.org/library/papers/33906958PubMed
931398337Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.Cell2019https://conductscience.org/library/papers/31398337PubMed
1035398347Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study.Gastroenterology2022https://conductscience.org/library/papers/35398347PubMed
1138662232Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study.Cancer Immunol Immunother2024https://conductscience.org/library/papers/38662232PubMed
1240376462A comprehensive multi-omics analysis uncovers the associations between gut microbiota and pancreatic cancer.Front Microbiol2025https://conductscience.org/library/papers/40376462PubMed
1326791914Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis.J Intern Med2016https://conductscience.org/library/papers/26791914PubMed
1438108398Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.Cancer Immunol Res2024https://conductscience.org/library/papers/38108398PubMed
1524321381Oncolytic vaccinia virus in combination with radiation shows synergistic antitumor efficacy in pancreatic cancer.Cancer Lett2014https://conductscience.org/library/papers/24321381PubMed
1636309208Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.Gastroenterology2023https://conductscience.org/library/papers/36309208PubMed
1725423447Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.Hum Gene Ther2015https://conductscience.org/library/papers/25423447PubMed
1829132246Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer.J Drug Target2018https://conductscience.org/library/papers/29132246PubMed
1929636538The gut microbiota influences anticancer immunosurveillance and general health.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29636538PubMed
2035756645Fecal Microbiota Transplantation Effectively Cures a Patient With Severe Bleeding Immune Checkpoint Inhibitor-Associated Colitis and a Short Review.Front Oncol2022https://conductscience.org/library/papers/35756645PubMed

See all 126 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42891339Microbiome-pancreatic cancer crosstalk: From tumor biology to therapeutic intervention.IMetaOmics2026https://conductscience.org/library/papers/42891339PubMed
42651018Metabolic Syndrome and Pancreatic Cancer: Linking Insulin Resistance, Inflammation, and Carcinogenesis.Diagnostics (Basel)2026https://conductscience.org/library/papers/42651018PubMed
42122957Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review.J Clin Med2026https://conductscience.org/library/papers/42122957PubMed
42073615Microbiome and Diet Interplay: An Emerging Frontier in PDAC Diagnosis and Prevention.Cancers (Basel)2026https://conductscience.org/library/papers/42073615PubMed
41471890Role of Probiotics in Enhancing Immune Function and Improving the Effectiveness of Treatments for Pancreatic Cancer.Microorganisms2025https://conductscience.org/library/papers/41471890PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41300985

GET https://conductscience.org/api/papers/v1/41300985/references?page=2